Proteomic analysis for detecting serum biomarkers related to smoking in humans

Chinese Medical Journal

Volumn 125, Issue 17, 2012, Pages 3027-3032

  Xiao, Dan ^a   Zhao, Li juan ^b   Chu, Shui lian ^c   Jing, Hang ^a,c   Wang Prof , Chen ^a,d  

^a Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d BEIJING HOSPITAL   (China)

Author keywords

Biological markers; Proteomics; Serum; Smoking

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DECISION TREE; DOWN REGULATION; FRACTIONATION; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PROTEIN MICROARRAY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING; TOBACCO DEPENDENCE; UPREGULATION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; SMOKING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84866055889     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.17.011     Document Type: Article

References (32)

1. Tobacco Free Initiative. Geneva: World Health Organization, 2006. (Accessed April 9, 2012 at http://www.who.int/tobacco/health_priority/en/index.html)
2. The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General. Washington, DC: Superintendent of Documents, U.S. Government Printing Office, 1988. (Accessed April 9, 2012 at http://profiles.nlm.nih.gov/ps/access/NNBBZD.pdf)
3. The ICD-10: Classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992. (Accessed April 9, 2012 at http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf)
4. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Washington, DC: Superintendent of Documents, U.S. Government Printing Office, 2010. (Accessed April 9, 2012 at http://www.surgeongeneral.gov/library/reports/tobaccosmoke/full_report.pdf)
5. Benowitz NL. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol 1996; 36: 597-613.
6. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-388.
7. Iho S, Tanaka Y, Takauji R, Kobayashi C, Muramatsu I, Iwasaki H, et al. Nicotine induces human neutrophils to produce IL-8 through the generation of peroxynitrite and subsequent activation of NF-kappaB. J Leukoc Biol 2003; 74: 942-951.
8. Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, Huston J, et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005; 201: 1113-1123.
9. Liu RH, Mizuta M, Matsukura S. The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes. J Pharmacol Exp Ther 2004; 310: 52-58.
10. Cormier A, Paas Y, Zini R, Tillement JP, Lagrue G, Changeux JP, et al. Long-term exposure to nicotine modulates the level and activity of acetylcholine receptors in white blood cells of smokers and model mice. Mol Pharmacol 2004; 66: 1712-1718.
11. Benhammou K, Lee M, Strook M, Sullivan B, Logel J, Raschen K, et al. [(3)H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day. Neuropharmacology 2000; 39: 2818-2829.
12. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Belmont, California: Wadsworth, 1984.
13. Nicholas B, Skipp P, Mould R, Rennard S, Davies DE, O'Connor CD, et al. Shotgun proteomic analysis of human-induced sputum. Proteomics 2006; 6: 4390-4401.
14. Landi C, Bargagli E, Magi B, Prasse A, Muller-Quernheim J, Bini L, et al. Proteome analysis of bronchoalveolar lavage in pulmonary langerhans cell histiocytosis. J Clin Bioinforma 2011; 1: 31.
15. Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin Chim Acta 2004; 347: 25-39.
16. Chan HP, Tran V, Lewis C, Thomas PS. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol 2009; 4: 172-178.
17. Airoldi L, Magagnotti C, Iannuzzi AR, Marelli C, Bagnati R, Pastorelli R, et al. Effects of cigarette smoking on the human urinary proteome. Biochem Biophys Res Commun 2009; 381: 397-402.
18. Cecconi D, Tessari M, Willé DR, Zoli M, Domenici E, Righetti PG, et al. Serum proteomic analysis during nicotine self-administration, extinction and relapse in rats. Electrophoresis 2008; 29: 1525-1533.
19. Tewari AK, Popova-Butler A, El-Mahdy MA, Zweier JL. Identification of differentially expressed proteins in blood plasma of control and cigarette smoke-exposed mice by 2-D DIGE/MS. Proteomics 2011; 11: 2051-2062.
20. Della Corte A, Tamburrelli C, Crescente M, Giordano L, D'Imperio M, Di Michele M, et al. Platelet proteome in healthy volunteers who smoke. Platelets 2012; 23: 91-105.
21. Verrills NM. Clinical proteomics: present and future prospects. Clin Biochem Rev 2006; 27: 99-116.
22. Gygi SP, Aebersold R. Mass spectrometry and proteomics. Curr Opin Chem Biol 2000; 4: 489-494.
23. Haab BB, Dunham MJ, Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2001; 2: RESEARCH0004.
24. Ahram M, Springer DL. Large-scale proteomics analysis of membrane proteins. Expert Rev Proteomics 2004; 1: 293-302.
25. Baumann S, Ceglarek U, Fiedler GM, Lembcke J, Leichtle A, Thiery J. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2005; 51: 973-980.
26. Zhang X, Leung SM, Morris CR, Shigenaga MK. Evaluation of a novel, integrated approach using functionalized magnetic beads, bench-top MALDI-TOF-MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasma. J Biomol Tech 2004; 15: 167-175.
27. Martorella A, Robbins R. Serum peptide profiling: identifying novel cancer biomarkers for early disease detection. Acta Biomed 2007; 78 Suppl 1: 123-128.
28. Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, et al. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and post-treatment head and neck cancer samples. Laryngoscope 2008; 118: 61-68.
29. Kim JY, Song HJ, Lim HJ, Shin MG, Kim JS, Kim HJ, et al. Platelet factor-4 is an indicator of blood count recovery in acute myeloid leukemia patients in complete remission. Mol Cell Proteomics 2008; 7: 431-441.
30. Musharraf SG, Hashmi N, Choudhary MI, Rizvi N, Usman A, Atta-ur-Rahman. Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS. Biomarkers 2012; 17: 223-230.
31. Bañez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam BL, et al. Diagnostic potential of serum proteomic patterns in prostate cancer. J Urol 2003; 170 (2 Pt 1): 442-446.
32. Mei J, Kolbin D, Kao HT, Porton B. Protein expression profiling of postmortem brain in schizophrenia. Schizophr Res 2006; 84: 204-213.